Thanks, Greg, and good morning, everyone. As Greg mentioned, the fourth quarter came in below our expectations. This was particularly true in South America, where the market environment has been challenging all year, impacting industry margins throughout the oilseed and grain value chains, including those of our joint ventures. We also felt the impact of a declining margin environment in North America from biofuel rate uncertainty. Now let's turn to the earnings highlights on Slide five. Reported fourth-quarter earnings per share was $4.36 compared to $4.18 in the fourth quarter of 2023. Reported results included a favorable mark-to-market timing difference of $1.25 per share and a net positive impact of $0.98 per share. Notable items were primarily related to the gain on the sale of our Sugar and Bioenergy joint venture, partially offset by transaction and integration costs associated with Viterra. Adjusted EPS was $2.13 in the fourth quarter, compared to $3.70 in the prior year. Adjusted core segment earnings before interest and taxes, or EBIT, was $548 million in the quarter, inclusive of the Ukraine business interruption insurance recovery of $52 million, versus EBIT of $881 million last year. In processing, strong results in Europe and Asia were offset by lower results in North America and South America, as well as in European softseeds. Higher merchandising results were driven by improved performance in Finance Services, Freight, and Global Grains, offsetting lower results in Global Refined and Specialty Oils. Lower results in North America were primarily due to the combination of a more balanced supply and demand environment and uncertainty related to U.S. biofuel policy. Results in Europe, South America, and Asia were also down due to lower margins, though the variances were much narrower. In milling, higher results in North America were more than offset by lower results in South America. The corporate and other increase in corporate expenses was primarily driven by lower performance-based compensation and various project-related expenses in the prior year. Other results related to our captive insurance and securitization programs and Bunge Ventures. Core results and non-core reflect only one month of income from the Sugar joint venture due to the recent close on the sale. Net interest expense of $62 million was down in the quarter compared to last year, reflecting lower net debt levels and interest rates. The increase in income tax expense for both the quarter and full year was primarily due to lower pretax income and earnings. Adjusting for notable items and mark-to-market timing differences, the full-year adjusted effective income tax rate was approximately 23% for the current and prior year. Let's turn to Slide six, where you can see our adjusted EPS and EBIT over the past five years. Strong performance during this period reflects a combination of a favorable market environment and excellent execution by our team. The recent trend indicates a more balanced supply and demand, translating into less volatility and lower margins. Slide seven details our capital allocation. For the full year, we generated approximately $1.7 billion of adjusted funds from operations. After allocating $451 million to sustaining CapEx, which includes maintenance, environmental health, and safety, we had approximately $1.2 billion of discretionary cash flow available. Of this amount, we paid $378 million in dividends, approximately $925 million in growth and productivity-related CapEx, two-thirds of which related to our growth pipeline of large multiyear investments, and repurchased $1.1 billion of Bunge Limited shares. $500 million of those repurchases were from the $728 million of cash proceeds received to date for the sale of our Sugar JV. This resulted in the use of $444 million of previously retained cash flow. Moving to Slide eight, we finished 2024 with a total CapEx spend of approximately $1.4 billion, which was in line with our last forecast. As we head into 2025, we expect CapEx to be in the range of $1.5 billion to $1.7 billion, reflecting the continued investment in our ongoing multiyear greenfield projects. This range is down from the preliminary estimate of $1.9 billion to $2 billion we provided you previously, reflecting our decision to not pursue some projects as well as timing changes related to existing projects. We continue to expect to return to a baseline run rate on CapEx levels during the second half of 2026. Moving to Slide nine, at year-end, readily marketable inventories, or RMI, exceeded our net debt by approximately $2.3 billion. The adjusted leverage ratio, which reflects our adjusted net debt to adjusted EBITDA, was 0.6 times at the end of the year. Slide ten highlights our liquidity position. At year-end, we had committed credit facilities of $8.7 billion, all of which were unused at the end of the year, providing ample liquidity to manage our ongoing capital needs. In addition, we had a cash balance of $3.3 billion, accumulated in large part as a result of the $2 billion of cash proceeds from the U.S. debt offering that we closed in September. All proceeds will be used to fund the cash portion of the Viterra transaction. In addition, we have a $6 million term loan commitment secured last year to refinance Viterra's outstanding bank debt upon closing the transaction. Please turn to Slide eleven. Our full-year adjusted ROIC was 11.1%, while our ROIC was 9.7%. Adjusting for construction in progress on large multiyear projects not yet operating and the excess cash on our balance sheet for the Viterra closing, adjusted ROIC would increase by approximately two percentage points and ROIC by approximately one percentage point. Our returns have declined from recent highs but remained well above our adjusted weighted average cost of capital of 7.7%. Moving to Slide twelve, for the year, we produced discretionary cash flow of approximately $1.2 billion and a cash flow yield of 11.1%, compared to our cost of equity of 8.2%. Please turn to Slide thirteen for our 2025 outlook. As Greg mentioned in his remarks, taking into account the current macro environment and market conditions, we expect full-year 2025 adjusted EPS to be approximately $7.75. This forecast excludes the impact of announced acquisitions expected to be closed during the year. In agribusiness, full-year results are forecasted to be down from last year, with lower results in processing where current performance in South America is expected to be more than offset by North American and European softseeds. Results in merchandising are forecasted to be down slightly from last year. Finally, in Specialty Oils, full-year results are expected to be down from last year, mainly driven by a more balanced supply and demand environment in North America. In corporate and other, full-year results are expected to be up from last year. Additionally, the company expects the following for 2025: an adjusted annual effective tax rate of 21% to 25%, interest expense in the range of $250 million to $280 million, capital expenditures in the range of $1.5 billion to $1.7 billion, and depreciation and amortization of approximately $490 million. With that, I'll turn things back over to Greg for some closing comments.